Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The <scp>pan‐JAK</scp> inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase <scp>IIb</scp> trial*
PaperCitations, authors & open-access status
The <scp>pan‐JAK</scp> inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase <scp>IIb</scp> trial* is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 89 citations, 2022 year and hybrid oa status.
89
Citations
2022
Year
hybrid
OA Status